QCLS
NASDAQ · Pharmaceuticals
Q/C Technologies Inc
$3.89
+0.19 (+5.14%)
Open$3.76
Previous Close$3.70
Day High$3.90
Day Low$3.69
52W High$44.40
52W Low$2.50
Volume—
Avg Volume1.87M
Market Cap30.94M
P/E Ratio—
EPS$-35.08
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.12M | 5.83M | 5.05M |
| Net Income | 729.3K | 769.8K | 662.9K |
| Profit Margin | 11.9% | 13.2% | 13.1% |
| EBITDA | 1.12M | 1.08M | 875.0K |
| Free Cash Flow | 457.4K | 470.8K | 287.5K |
| Rev Growth | +22.0% | +12.4% | +6.3% |
| Debt/Equity | 0.30 | 0.26 | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |